APA citiranje

Ismail, E., Nofal, O. K. J., Sakthiswary, R., Shaharir, S. S., & Sridharan, R. (2016). The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis. PLoS One.

Citação norma Chicago

Ismail, Endom, Omimah Khaled Jaber Nofal, Rajalingham Sakthiswary, Syahrul Sazliyana Shaharir, and Radhika Sridharan. "The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis." PLoS One 2016.

MLA citiranje

Ismail, Endom, et al. "The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis." PLoS One 2016.